Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19.
作者信息
Shahridan Faiez Tasnim, Singanayagam Aran
机构信息
Department of Infectious Disease Imperial College London London, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1370-1372. doi: 10.1164/rccm.202203-0526ED.
Abstract
摘要
相似文献
1
Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19.恰到好处：淋巴细胞减少在重症 COVID-19 中的功能重要性
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1370-1372. doi: 10.1164/rccm.202203-0526ED.
2
CD4 T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent.严重 COVID-19 疾病中的 CD4 T 细胞功能障碍依赖于肿瘤坏死因子-α/肿瘤坏死因子受体 1。
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1403-1418. doi: 10.1164/rccm.202111-2493OC.
3
Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.2 型糖尿病 COVID-19 患者的高血糖与淋巴细胞减少症及疾病严重程度相关。
J Diabetes Complications. 2021 Feb;35(2):107809. doi: 10.1016/j.jdiacomp.2020.107809. Epub 2020 Nov 26.
4
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease.中性粒细胞减少和淋巴细胞减少，严重 COVID-19 疾病中的未知轴。
PLoS Pathog. 2021 Sep 2;17(9):e1009850. doi: 10.1371/journal.ppat.1009850. eCollection 2021 Sep.
5
Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules.肿瘤坏死因子-α诱导老年人T细胞凋亡：肿瘤坏死因子受体-I及下游信号分子的作用
Exp Gerontol. 2002 Jan-Mar;37(2-3):293-9. doi: 10.1016/s0531-5565(01)00195-4.
6
Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients.线粒体功能障碍与 COVID-19 患者的急性 T 淋巴细胞减少症和功能障碍相关。
Front Immunol. 2022 Jan 14;12:799896. doi: 10.3389/fimmu.2021.799896. eCollection 2021.
7
Idiopathic CD4 Lymphopenia: Severe CD4 Lymphopenia in the Absence of Human Immunodeficiency Virus Infection.特发性CD4淋巴细胞减少症：在无人类免疫缺陷病毒感染情况下的严重CD4淋巴细胞减少症。
Isr Med Assoc J. 2016 Oct;18(10):627-629.
8
Host Response to Infection: Not All Lymphopenia Is Created Equal in SARS-CoV-2.宿主对感染的反应：在新冠病毒感染中，并非所有淋巴细胞减少都是一样的。
Am J Respir Crit Care Med. 2024 Feb 15;209(4):351-352. doi: 10.1164/rccm.202312-2265ED.
9
The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.新型冠状病毒肺炎患者外周血 CD4+T 淋巴细胞及炎症因子的变化。
PLoS One. 2020 Sep 25;15(9):e0239532. doi: 10.1371/journal.pone.0239532. eCollection 2020.
10
T cell apoptosis characterizes severe Covid-19 disease.T 细胞凋亡是严重新冠肺炎疾病的特征。
Cell Death Differ. 2022 Aug;29(8):1486-1499. doi: 10.1038/s41418-022-00936-x. Epub 2022 Jan 22.
引用本文的文献
1
COVID-19: from immune response to clinical intervention.新型冠状病毒肺炎：从免疫反应到临床干预
Precis Clin Med. 2024 Jul 18;7(3):pbae015. doi: 10.1093/pcmedi/pbae015. eCollection 2024 Sep.
2
Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y.Ins215KLRS 和 H655Y 非 RBD 突变增强了 N501Y 赋予的 SARS-CoV-2 小鼠感染性。
Biol Direct. 2022 Jun 5;17(1):14. doi: 10.1186/s13062-022-00325-x.
本文引用的文献
1
CD4 T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent.严重 COVID-19 疾病中的 CD4 T 细胞功能障碍依赖于肿瘤坏死因子-α/肿瘤坏死因子受体 1。
Am J Respir Crit Care Med. 2022 Jun 15;205(12):1403-1418. doi: 10.1164/rccm.202111-2493OC.
2
Lymphopenia as a Predictor for Adverse Clinical Outcomes in Hospitalized Patients with COVID-19: A Single Center Retrospective Study of 4485 Cases.淋巴细胞减少作为COVID-19住院患者不良临床结局的预测指标：一项对4485例病例的单中心回顾性研究
J Clin Med. 2022 Jan 28;11(3):700. doi: 10.3390/jcm11030700.
3
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.ACE2 是新型 COVID-19 小鼠模型中 SARS-CoV-2 的关键体内受体，该模型具有 TNF-α 和 IFNγ 驱动的免疫病理学特征。
Elife. 2022 Jan 13;11:e74623. doi: 10.7554/eLife.74623.
4
Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.系统评价与荟萃分析：接受抗 TNF 治疗的患者的 COVID-19 结局。
Aliment Pharmacol Ther. 2022 Jan;55(2):154-167. doi: 10.1111/apt.16717. Epub 2021 Dec 8.
5
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.严重 COVID-19 患者 T 细胞动态平衡和功能的严重失调。
Allergy. 2021 Sep;76(9):2866-2881. doi: 10.1111/all.14866. Epub 2021 Jun 30.
6
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.疾病谱中的炎症特征表明 GM-CSF 在重症 COVID-19 中具有显著作用。
Sci Immunol. 2021 Mar 10;6(57). doi: 10.1126/sciimmunol.abg9873.
7
Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study.淋巴细胞减少作为COVID-19患者预后的生物学预测指标：一项全国性队列研究。
Cancers (Basel). 2021 Jan 26;13(3):471. doi: 10.3390/cancers13030471.
8
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment.越来越多的证据表明，在新冠病毒病治疗中，抗TNF治疗需要优先进行试验。
Lancet Rheumatol. 2020 Nov;2(11):e653-e655. doi: 10.1016/S2665-9913(20)30309-X. Epub 2020 Sep 5.
9
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
10
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).新型冠状病毒病（COVID-19）患者 T 细胞减少和功能耗竭。
Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.
Zotero 插件